Advertisement
CAH vs YI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a StrongBuy and YI is a Hold.
CAH's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for CAH turned positive on November 04, 2026. Looking at past instances where CAH's MACD turned positive, the stock continued to rise in 32 of 42 cases over the following month. The odds of a continued upward trend are 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on CAH as a result. In 64 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
CAH moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CAH crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +1.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where CAH advanced for three days, in 262 of 392 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
The Aroon Indicator entered an Uptrend today. In 188 of 310 cases where CAH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.
CAH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 7 (best 1 - 100 worst), indicating outstanding price growth. CAH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-21.824) is normal, around the industry mean (14.423). CAH has a moderately high P/E Ratio (37.376) as compared to the industry average of (11.188). Projected Growth (PEG Ratio) (1.105) is also within normal values, averaging (2.016). Dividend Yield (0.008) settles around the average of (0.134) among similar stocks. P/S Ratio (0.217) is also within normal values, averaging (4.260).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Momentum Indicator for YI turns negative, indicating new downward trend
YI saw its Momentum Indicator move below the 0 level on November 09, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 76 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where YI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for YI entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where YI's RSI Oscillator exited the oversold zone, 31 of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 58 of 74 cases where YI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for YI just turned positive on November 03, 2026. Looking at past instances where YI's MACD turned positive, the stock continued to rise in 28 of 39 cases over the following month. The odds of a continued upward trend are 72%.
Following a +7.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where YI advanced for three days, in 193 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
YI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.225) is normal, around the industry mean (14.423). P/E Ratio (-0.244) is within average values for comparable stocks, (11.188). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.016). Dividend Yield (0.000) settles around the average of (0.134) among similar stocks. P/S Ratio (0.017) is also within normal values, averaging (4.260).
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. YI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. YI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.
CAH | YI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 32 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 30 Undervalued | 16 Undervalued | |
PROFIT vs RISK RATING 1..100 | 2 | 100 | |
SMR RATING 1..100 | 99 | 100 | |
PRICE GROWTH RATING 1..100 | 7 | 76 | |
P/E GROWTH RATING 1..100 | 21 | 18 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
YI's Valuation (16) in the Drugstore Chains industry is in the same range as CAH (30) in the Medical Distributors industry. This means that YI’s stock grew similarly to CAH’s over the last 12 months.
CAH's Profit vs Risk Rating (2) in the Medical Distributors industry is significantly better than the same rating for YI (100) in the Drugstore Chains industry. This means that CAH’s stock grew significantly faster than YI’s over the last 12 months.
CAH's SMR Rating (99) in the Medical Distributors industry is in the same range as YI (100) in the Drugstore Chains industry. This means that CAH’s stock grew similarly to YI’s over the last 12 months.
CAH's Price Growth Rating (7) in the Medical Distributors industry is significantly better than the same rating for YI (76) in the Drugstore Chains industry. This means that CAH’s stock grew significantly faster than YI’s over the last 12 months.
YI's P/E Growth Rating (18) in the Drugstore Chains industry is in the same range as CAH (21) in the Medical Distributors industry. This means that YI’s stock grew similarly to CAH’s over the last 12 months.
| CAH | YI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 52% | 2 days ago 76% |
| Stochastic ODDS (%) | 2 days ago 46% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 74% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 76% | 2 days ago 72% |
| TrendWeek ODDS (%) | 2 days ago 67% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 65% | 2 days ago 90% |
| Advances ODDS (%) | 2 days ago 67% | 9 days ago 77% |
| Declines ODDS (%) | 15 days ago 43% | 6 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 44% | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 61% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CAH’s FA Score shows that 4 FA rating(s) are green while YI’s FA Score has 2 green FA rating(s).
- CAH’s FA Score: 4 green, 1 red.
- YI’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CAH’s TA Score shows that 6 TA indicator(s) are bullish while YI’s TA Score has 5 bullish TA indicator(s).
- CAH’s TA Score: 6 bullish, 4 bearish.
- YI’s TA Score: 5 bullish, 3 bearish.
Price Growth
CAH (@Medical Distributors) experienced а +9.43% price change this week, while YI (@Medical Distributors) price change was -1.66% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was -12.70%. For the same industry, the average monthly price growth was -15.74%, and the average quarterly price growth was -20.34%.
Reported Earning Dates
CAH is expected to report earnings on Feb 04, 2027.
YI is expected to report earnings on Dec 16, 2026.
Industries' Descriptions
@Medical Distributors (-12.70% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
Advertisement
CAH and
Correlation & Price change
A.I.dvisor indicates that over the last year, CAH has been closely correlated with MCK. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if CAH jumps, then MCK could also see price increases.
| Ticker / NAME | Correlation To CAH | 1D Price Change % | ||
|---|---|---|---|---|
| CAH | 100% | +0.91% | ||
| MCK - CAH | 71% Closely correlated | +2.19% | ||
| COR - CAH | 61% Loosely correlated | +0.85% | ||
| HSIC - CAH | 9% Poorly correlated | +0.37% | ||
| AHG - CAH | 4% Poorly correlated | -2.34% | ||
| FOCL - CAH | 2% Poorly correlated | -0.57% | ||
More | ||||
YI and
Correlation & Price change
A.I.dvisor tells us that YI and LFMD have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YI and LFMD's prices will move in lockstep.